Activation of the c-JunN-terminal Kinase/ActivatingTranscription Factor 3 (ATF3) Pathway Characterizes Effective ArylatedDiazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs.

Details

Language :

English

ISSN :

00222623

Volume :

54

Issue :

22

Database :

Supplemental Index

Journal :

Journal of Medicinal Chemistry

Publication Type :

Academic Journal

Accession number :

67347127

Full Text :

https://doi.org/10.1021/jm2004128